CJC 1295(without DAC)5mg IPA 5mg 10vials/box

CJC 1295(without DAC)5mg IPA 5mg 10vials/box

CP10 5mg 5mg 10vials/box
$120.00
Skip to product information
CJC 1295(without DAC)5mg IPA 5mg 10vials/box

CJC 1295(without DAC)5mg IPA 5mg 10vials/box

$120.00
Option

Product Basic Information

Full Name: CJC1295 5mg + Ipamorelin 5mg Lyophilized Compound Powder (without DAC modification)

Form: Sterile peptide lyophilized powder, individually packaged in vials

Uses: Reagent for in vitro research experiments related to growth hormone secretion regulation, metabolic optimization, and body repair.

II. Core Functions of Each Component

1. CJC 1295 without DAC (5mg)

Mechanism of Action: A synthetic GHRH growth hormone-releasing hormone analog without long-acting DAC modification groups, providing a mild and controllable action cycle. It targets the pituitary gland to stimulate growth hormone synthesis and release, regulating the GH/IGF-1 signaling pathway.

Core Scientific Efficacy:

Stimulates endogenous growth hormone secretion from the pituitary gland, increases cellular IGF-1 expression levels, and is suitable for aging and growth-related cell models;

Regulates systemic glucose and lipid metabolism, reduces lipid accumulation, and improves cellular energy metabolism efficiency;

Promotes fibroblast and chondrocyte proliferation, participating in research on tissue repair mechanisms;

Balances the HPA axis and alleviates oxidative stress damage to endocrine cells.

2. Ipamorelin (IPA, 5mg)

Mechanism of Action: A highly selective GHS (growth hormone secretagogue) that targets and regulates GH release only, without interfering with cortisol or prolactin secretion.

Core Scientific Benefits:

* Pulsatically and steadily increases growth hormone expression, optimizing cellular nighttime repair-related indicators;

* Reduces cellular inflammation levels, decreases tissue breakdown, and maintains a lean cell ratio;

* Improves nerve cell fatigue and assists in in vitro controlled experiments on sleep-related mechanisms.

III. Synergistic Advantages of the Combination

* Dual-pathway synergistic enhancement of GH expression

* CJC1295 acts on the pituitary gland to promote GH synthesis, while Ipamorelin stimulates GH release. The two pathways are complementary, resulting in a greater enhancement of growth hormone-related indicators than a single component in experiments.

* Milder and More Stable Endocrine Environment

* The combination does not significantly increase cortisol, avoiding endocrine imbalances caused by single high-concentration reagents, making it suitable for long-term cell culture controlled experiments.

* Wide Range of Applications

* Can be used alone in anti-aging and metabolic in vitro models, and can also be combined with insulin, fat-reducing peptides, and repair peptides for combined mechanism studies.

* IV. Reconstitution and Storage Specifications

Reconstitution Solvent: 0.6% acetic acid aqueous solution or sterile water for injection can be used for reconstitution.

Storage Requirements

Unopened lyophilized powder: Store at 2-8℃ protected from light. Freezing is strictly prohibited, as freezing will damage the peptide's spatial structure and lead to activity loss.

Reconstituted liquid: Store at 4℃ protected from light.

You may also like